Inventor Navjot Singh of McKinsey New Ventures provides insights on disruption for corporate strategy. Mark Weber of the MIT Media Lab gives the introduction.

The MIT Venture Capital + Innovation Conference is held annually in February at the MIT Sloan School of Management. Thank you to our lead sponsor IBM Research, as well as Solvay, Wilmer Hale, Finnegan, The MIT Industrial Liaison Program, the MIT Startup Exchange, and Startup Hub Boston. Visit http://www.mitvcconference.com/.

Dr. Navjot Singh is a leader in McKinsey's Pharmaceuticals and Medicals practice and Public Sector Practice. He is also the Managing Partner of the Boston Office, and is a leader in the Corporate Finance and Strategy Practice. He is also the co-founder of the Center of Asset Optimization where McKinsey does Asset level work with Innovative, Specialty and Generics companies all around the world. He has over 15 years of experience at McKinsey and over 6 years at GE. He has broad experience serving pharmaceutical companies across the value chain. Some of his experiences include: extensive experiences across the pharmaceutical industry in R&D strategies, operational effectiveness, integration management and leading several engagements with Private Equity clients investing in the Health Care sector

Dr. Singh received a Ph.D. in Chemical Engineering from the University of Minnesota, and an M.B.A. from Rensselaer Polytechnic Institute. He has a B. Tech from Indian Institute of Technology. He is a co-author of more than a dozen peer reviewed articles and external presentations on pharmaceutical R&D. He is also a co-inventor on over 15 patents and has published in reputed journals such as In Vivo and Nature Drug Discovery. He is also the Chair of the Board for the Greater Boston Chamber of Commerce.